Ignite Creation Date:
2025-12-25 @ 2:49 AM
Ignite Modification Date:
2026-03-08 @ 1:07 AM
Study NCT ID:
NCT02673333
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-04-20
First Post:
2016-02-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-02
Start Date Type:
None
Primary Completion Date:
2019-01-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-02
Completion Date Type:
ESTIMATED
First Submit Date:
2016-02-01
First Submit QC Date:
None
Study First Post Date:
2016-02-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-12-13
Results First Submit QC Date:
None
Results First Post Date:
2020-01-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-14
Last Update Post Date:
2025-04-20
Last Update Post Date Type:
ACTUAL